A cell-specific gene therapy has been shown to silence pain encoding neurons in mice, offering a potential alternative to ...

A Phase 2 trial at Imperial College London found that a single intravenous dose of DMT rapidly reduced depressive symptoms ...

Researchers introduced a yeast enzyme, ScURA, into human cells, enabling nucleotide synthesis independent of mitochondrial ...

A new human spinal cord organoid model replicates key injury responses, such as inflammation, cell loss, and scar formation.

Researchers developed a scalable platform combining high-throughput chemistry and live-cell screening to discover molecular ...

Researchers found that a single 21.5mg dose of DMT reduced depression symptoms compared to placebo in patients with treatment ...

Discover how adding crushed silicate rocks to crop soils could improve the global carbon footprint of the farming industry.

Researchers report that acetazolamide prevented adverse brain changes caused by cocaine withdrawal in mice, suggesting the approved drug could be repurposed to target relapse-related pathways.

A crucial developmental process in the brain’s hypothalamus may influence how susceptible individuals are to obesity.

Researchers identified mechanisms that limit CD4+ Th1 cell differentiation during chronic viral infection. They discovered an intermediate precursor subset and showed that PD-1/PD-L1 signaling and the ...

Researchers have identified the neurogenic progenitor that give rise to dopaminergic neurons, the primary neurons affected in Parkinson’s disease.

In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.